This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Winters ME, Basic clinical pharmacokinetics. Winter ME, Applied Therapeutic Inc. Vancouver, WA 1994.
Zhang Y. Benet LZ. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clinical Pharmacokinetics. 40(3):159–68, 2001
Olyaei AJ, Bennett WM. “The Effect of Renal Failure on Drug Handling”. Oxford Textbook of Critical Care, 1996.
Benedetti P. de Lalla F. Antibiotic therapy in acute renal failure. Contributions to Nephrology. (132):136–45, 2001.
Olyaei AJ, deMattos AM, Bennett WM. “Prescribing Drugs in Renal Failure”. Brenner and Rector’s, The Kidney, 2000.
Olyaei AJ, deMattos AM, Bennett WM. “Drug-drug Interaction and most Commonly Used Drug in Transplant Recipients”. Primer on Transplantation, American Society of Transplantation. 2000
Olyaei AJ “Drug Dosing in Renal Failure” in Treatment Strategies In Nephrology and Hypertension. By Bennett 1st edition. PocketMedicine.com Inc 2001
Olyaei AJ, deMattos AM, Bennett WM “Principle of Drug Usage in Dialysis Patients” Dialysis Therapy, Hanley & Belfus Inc. Medical Publishers. May 2001
Olyaei AJ, deMattos, Bennett WM, Drug usage in dialysis patients. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical dialysis. Norwalk, NJ: Appleton and Lange; 2001.
Bennett WM. Guide to drug dosage in renal failure. In: Speight TM, Holford N, eds. Avery’s drug treatment, 4th edn. Auckland: ADIS International; 1997:1725–92.
Beauchamp D, Labrecque G. Aminoglycoside nephrotoxicity: do time and frequency of administration matter?. Current Opinion in Critical Care 2001:7: 401–408.
Livornese LL, Jr., Slavin D, Benz RL, Ingerman MJ, Santoro J. Use of antibacterial agents in renal failure. Infectious Disease Clinics of North America 2001:15: 983–1002.
Chertow GM, Lee J, Kuperman GJ et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001:286: 2839–2844.
Bugge JF. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiologica Scandinavica 2001:45:929–934.
Izzedine H, Launay-Vacher V, Baumelou A, Deray G. An appraisal of antiretroviral drugs in hemodialysis. [Review] [47 refs]. Kidney International 2001:60: 821–830.
Subach RA, Marx MA. Drug dosing in acute renal failure: the role of renal replacement therapy in altering drug pharmacokinetics. Advances in Renal Replacement Therapy 1998:5: 141–147.
Joy MS, Matzke GR, Armstrong DK, Marx MA, Zarowitz BJ. A primer on continuous renal replacement therapy for critically ill patients. Annals of Pharmacotherapy 1998:32: 362–375.
Joos B, Schmidli M, Keusch G. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration. Nephrology Dialysis Transplantation 1996:11: 1582–1585.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Kluwer Academic Publishers
About this chapter
Cite this chapter
Olyaei, A.J., Demattos, A.M., Bennett, W.M. (2003). Drug dosage in renal failure. In: de Broe, M.E., Porter, G.A., Bennett, W.M., Verpooten, G.A. (eds) Clinical Nephrotoxins. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2586-6_35
Download citation
DOI: https://doi.org/10.1007/1-4020-2586-6_35
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-1277-8
Online ISBN: 978-1-4020-2586-0
eBook Packages: Springer Book Archive